Last Call for canSERV Third Open Call Funding
One document
more
Stories about Krankheit
Event Announcement: VIROFIGHT Hybrid Symposium
One documentmoreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
moreLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
One documentmore- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore - 2
Record financing rounds at the Munich biotech hub
One documentmore Bosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
morecanSERV relaunches Open Call for Service Provision
One documentmorePress release: STADA continues strong growth journey in the first half of 2024
One documentmoreBosch Healthcare Solutions GmbH
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling point
morecanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 Documentsmore- 4
Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science Prizes
One documentmore New Study: Father's Diet Before Conception Influences Children's Health
morecanSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore New Study: Night-time heat significantly increases the risk of stroke
moreLAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
One documentmore- 3
canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
One documentmore Advanced Brain Science Without Coding Expertise
moreDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
moreScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets
morePress release: STADA continues with double-digit sales and profit growth in 2023
One documentmore- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
more Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
moreLeipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
One documentmoreTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
moreWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
moreStrengthening the Direct Sales and Service System for Business Expansion in Italy
One documentmoreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
more
12345Next